ticagrelor

Generic: ticagrelor

Labeler: sciegen pharmaceuticals inc
NDC Directory HUMAN PRESCRIPTION DRUG ANDA Inactive Finished

Drug Facts

Product Profile

Brand Name ticagrelor
Generic Name ticagrelor
Labeler sciegen pharmaceuticals inc
Dosage Form TABLET
Routes
ORAL
Active Ingredients

ticagrelor 90 mg/1

Manufacturer
ScieGen Pharmaceuticals INC

Identifiers & Regulatory

Product NDC 50228-522
Product ID 50228-522_3d85dd4c-b57c-44f8-bb8f-c3f04545c09d
Product Type HUMAN PRESCRIPTION DRUG
Marketing Category ANDA
Application Number ANDA218962
Listing Expiration 2026-12-31
Marketing Start 2025-10-09

Pharmacologic Class

Established (EPC)
p2y12 platelet inhibitor [epc]
Mechanism of Action
p2y12 receptor antagonists [moa] cytochrome p450 3a4 inhibitors [moa] p-glycoprotein inhibitors [moa]
Physiologic Effect
decreased platelet aggregation [pe]

Normalized Code Variants

Searchable formats for this product NDC code

Digits Only 50228522
Hyphenated Format 50228-522

Supplemental Identifiers

RxCUI
1116635 1666332
UPC
0350228521109 0350228521604 0350228521307 0350228522601 0350228522106 0350228522304
UNII
GLH0314RVC
NUI
N0000182142 N0000008832 N0000182143 N0000182141 N0000185503

Packaging Origin

Original Packager
true

Resolved Product View

Precedence rule: structured NDC data is preferred, falling back to linked label metadata when unavailable. Source tags show the origin of each value.

Resolved Identity

Brand Name ticagrelor (source: ndc)
Generic Name ticagrelor (source: ndc)
Application Number ANDA218962 (source: ndc)
Routes
ORAL
source: ndc

Resolved Composition

Strengths
  • 90 mg/1
source: ndc
Packaging
  • 1000 TABLET in 1 BOTTLE (50228-522-10)
  • 30 TABLET in 1 BOTTLE (50228-522-30)
  • 60 TABLET in 1 BOTTLE (50228-522-60)
source: ndc

Packages (3)

50228-522-10 1000 TABLET in 1 BOTTLE (50228-522-10) 50228-522-30 30 TABLET in 1 BOTTLE (50228-522-30) 50228-522-60 60 TABLET in 1 BOTTLE (50228-522-60)

Ingredients (1)

ticagrelor (90 mg/1)

Linked Drug Pages (1)

ticagrelor ndc-match (0.9)

Raw FDA Data

View complete raw FDA NDC JSON payload 
{"route": ["ORAL"], "spl_id": "3d85dd4c-b57c-44f8-bb8f-c3f04545c09d", "openfda": {"nui": ["N0000182142", "N0000008832", "N0000182143", "N0000182141", "N0000185503"], "upc": ["0350228521109", "0350228521604", "0350228521307", "0350228522601", "0350228522106", "0350228522304"], "unii": ["GLH0314RVC"], "rxcui": ["1116635", "1666332"], "spl_set_id": ["40ac26dc-2570-de7e-e063-6294a90ade72"], "pharm_class_pe": ["Decreased Platelet Aggregation [PE]"], "pharm_class_epc": ["P2Y12 Platelet Inhibitor [EPC]"], "pharm_class_moa": ["P2Y12 Receptor Antagonists [MoA]", "Cytochrome P450 3A4 Inhibitors [MoA]", "P-Glycoprotein Inhibitors [MoA]"], "manufacturer_name": ["ScieGen Pharmaceuticals INC"], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "1000 TABLET in 1 BOTTLE (50228-522-10)", "package_ndc": "50228-522-10", "marketing_start_date": "20251009"}, {"sample": false, "description": "30 TABLET in 1 BOTTLE (50228-522-30)", "package_ndc": "50228-522-30", "marketing_start_date": "20251009"}, {"sample": false, "description": "60 TABLET in 1 BOTTLE (50228-522-60)", "package_ndc": "50228-522-60", "marketing_start_date": "20251009"}], "brand_name": "ticagrelor", "product_id": "50228-522_3d85dd4c-b57c-44f8-bb8f-c3f04545c09d", "dosage_form": "TABLET", "pharm_class": ["Cytochrome P450 3A4 Inhibitors [MoA]", "Decreased Platelet Aggregation [PE]", "P-Glycoprotein Inhibitors [MoA]", "P2Y12 Platelet Inhibitor [EPC]", "P2Y12 Receptor Antagonists [MoA]"], "product_ndc": "50228-522", "generic_name": "ticagrelor", "labeler_name": "ScieGen Pharmaceuticals INC", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "ticagrelor", "active_ingredients": [{"name": "TICAGRELOR", "strength": "90 mg/1"}], "application_number": "ANDA218962", "marketing_category": "ANDA", "marketing_start_date": "20251009", "listing_expiration_date": "20261231"}